Israel Stocks: Elbit Imaging, Flowsense, Magic, Partner

Israel’s TA-25 Index (TA-25) rose for the fourth time this week, advancing 0.5 percent to 1,128.55, at the 4:30 p.m. close in Tel Aviv. The measure has gained 4 percent this year after dropping 18 percent in 2011. Investors traded about 955 million shekels ($249 million) of shares and convertible securities, according to bourse data.

The following stocks rose or fell today. Symbols are in parentheses.

Elbit Imaging Ltd. (EMIT) closed 1.5 percent lower at 12.25 shekels, after gaining as much as 4.1 percent earlier in the day. The shares jumped 20 percent yesterday after an affiliate of the investor in real estate and medical companies sold shopping centers in the U.S. for $1.43 billion.

Excellence Investments Ltd. (EXCE) gained 3.8 percent to 43.63 shekels, the highest level since Nov. 7. The investment company, which underwrites new securities and provides financial services, had its ILA rating confirmed at Standard & Poor’s Maalot.

Flowsense Medical Ltd. (FLSN) surged 13 percent, the most since Oct. 5, to 0.087 shekel. The maker of an automated urine-monitor system said it completed the first stage of testing of a system in the U.S.

Magic Software Enterprises Ltd. (MGIC) climbed the most since Nov. 13, surging 7.6 percent to 21.77 shekels, or the equivalent of $5.69. The software technology company’s U.S. traded shares increased 5.8 percent to $5.57 yesterday.

Scailex Corp. (SCIX) rose the most in a week, gaining 2.4 percent to 19.58 shekels. Apax Partners LLP is in advanced negotiations to acquire a controlling stake in Partner Communications Co. (PTNR) , Calcalist reported today. Scailex is looking to sell part of its stake in Partner. Shares of Partner gained 2.3 percent to 34.36 shekels.

Teva Pharmaceutical Industries Ltd. (TEVA) declined the most since Dec. 29, dropping 1.2 percent to 169.80 shekels, or the equivalent of $44.34. The company’s U.S. shares declined 2 percent to $43.95 yesterday.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.